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Introduction: Notch signalling has been shown to control cytotrophoblast (CTB) proliferation, differen-
tiation and motility suggesting that the conserved signalling pathway could be critical for human
placental development. Since individual Notch receptors have not been elucidated, we herein investi-
gated expression pattern and function of Notch2 in different ﬁrst trimester trophoblast subpopulations.
Methods: Localisation of Notch2 was analysed in ﬁrst trimester placental and decidual tissues using
immunoﬂuorescence. Notch2 transcript and protein levels were studied by qRT-PCR and Western blot-
ting in proliferative EGF receptor (EGFR)þ and differentiated HLA-Gþ CTBs, respectively, isolated from
early placentae by MACS. CTB migration through ﬁbronectin-coated transwells as well as proliferation
(EdU labelling) in ﬂoating villous explant cultures and primary CTBs were investigated in the presence of
Notch2 siRNAs or speciﬁc antibodies blocking Notch2 cleavage.
Results: In tissue sections Notch2 expression was higher in HLA-Gþ distal cell column trophoblasts
(dCCTs) compared to proximal CCTs. Accordingly, expression of Notch2 mRNA and protein were elevated
in isolated HLA-Gþ CTBs compared to EGFRþ CTBs. Notch2 was also detectable in interstitial CTBs as well
as in intramural CTBs associated with maternal decidual vessels. Antibody-mediated inhibition of Notch2
signalling did not affect proliferation, but increased migration of SGHPL-5 cells and primary CTBs.
Similarly, Notch2 siRNA treatment promoted trophoblast motility.
Discussion: Notch2 is present in differentiated cells of the extravillous trophoblast lineage, such as dCCTs,
interstitial and intramural CTBs, suggesting diverse roles of the particular receptor. Notch2 signalling,
activated by cellecell contact of neighbouring dCCTs, could attenuate trophoblast migration.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Human placentation involves the generation of diverse
trophoblast subtypeswhich are essential for subsequent embryonic
development. Whereas the villous syncytium produces hormones
to maintain pregnancy, anchoring villi attaching to the maternal
uterus give rise to extravillous trophoblasts (EVTs) invading
decidual stroma and vessels. Interstitial cytotrophoblasts (iCTBs)
approach the wall of maternal spiral arteries and promote vessel
remodelling in conjunction with uterine NK (uNK) cells and
endovascular cytotrophoblasts (eCTBs), the latter replacingna, Department of Obstetrics
nit, Waehringer Guertel 18-
fax: þ43 1 40400 78420.
t (M. Kn€oﬂer).
r Ltd. This is an open access articlematernal endothelial cells [1,2]. These processes are required for
continuous, low pressure blood ﬂow to the placenta, thereby
ensuring adequate nutrition of the fetus and preventing oxidative
stress [3]. Abnormal changes in myometrial vessel remodelling
have been detected in pregnancy diseases such as preeclampsia and
intrauterine growth restriction [4,5]; their causes however remain
largely elusive. Failures in trophoblast proliferation and EVT dif-
ferentiation could be involved since CTBs, isolated from pre-
eclamptic patients, lack critical lineage marker genes and show
changes in gene expression pattern when differentiating in vitro
[6,7]. However, our knowledge about the differentiation program of
the anchoring villus is only scarce. Whereas many different studies
investigated soluble factors regulating trophoblast migration [8,9],
numerous key questions concerning placental development, such
as mechanisms controlling cell column proliferation and differen-
tiation of progenitors into distinct EVT subtypes, have not been
unravelled.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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control stem cell renewal, cell fate decisions and differentiation
[10,11]. Upon cellecell contact, membrane-anchored ligands, the
Serrate-like ligands (Jagged1 and 2) and the Delta-like ligands
(DLL1, 3 and 4), bind to the different Notch receptors (Notch1e4)
and thereby provoke activation of the pathway. Subsequent
downstream signalling involves two proteolytic cleavage steps
executed by members of a disintegrin and metalloproteinase
(ADAM) family and g-secretase ﬁnally generating the Notch intra-
cellular domain (NICD) which translocates to the nucleus. Upon
binding NICD converts the transcription factor recombination
signal binding protein for immunoglobulin kappa J region (RBPJk)
into a transcriptional activator. After recruitment of additional co-Fig. 1. Expression of Notch2 in ﬁrst trimester placental and decidual tissues. Cytokeratin 7 (K
DAPI. Representative examples showing localisation of Notch2 in cell column trophoblasts (ﬁ
12th week placenta, scale bars represent 100 mm), in interstitial cytotrophoblasts (iCTBs)
intramural cytotrophoblasts (imCTB), associated with maternal blood vessels (fourth panel;
6th and 12th week of gestation) expression was weaker in pCCTs and villous cytotropho
magniﬁcations, showing HLA-G and Notch2 in dCCTs. Notch2 was also present in the villou
staining as published [26]. VE-cadherin (CDH5) stained endothelial cells (EC) in spiral arteri
represent 100 mm). Partial disruption of the maternal EC layer/VE-cadherin staining depicte
Notch2 staining. Selected areas (ii) and (iii) on the right-hand side represent magniﬁed ovactivators of the Mastermind-like (MAML) family the NICD-RBPJk
complex induces target genes involved in proliferation, cell lineage
determination and differentiation [12].
Recent evidence suggests that the Notch signalling pathway
could also be critically involved in placental development and
function. Mice harbouring homozygous deletions of different Notch
signalling components displayed defects in chorioallantoic
branching, labyrinth formation/function or chorion-allantoic fusion
[13]. Moreover, Notch2 mutant mice die around E11.5 due to
reduced blood delivery to the placenta and lower numbers of blood
sinuses within the labyrinth [14]. Conditional deletion of Notch2 in
progenitors of the invasive trophoblast lineage reduced endovas-
cular invasion, diameter of trophoblast-lined vascular canals andRT7) and HLA-G were used to mark all CTB subtypes and EVTs. Nuclei are stained with
rst panel; dCCT, distal cell column trophoblast; pCCT, proximal cell column trophoblast;
of the decidua basalis (second panel; 12th week, scale bars represent 50 mm), and in
12th week decidua basalis, digitally zoomed). In all placentae analysed (n ¼ 4, between
blasts (vCTB) compared to non-proliferative, HLA-Gþ dCCTs. Inserts (i) depict digital
s core (VC) as well as in decidual stromal cells (DSC), some of which showed nuclear
es (SA) present in maternal decidua (third panel; 12th week decidua basalis, scale bars
d in (ii) suggested on-going vessel remodelling. imCTBs in (ii) and (iii) showed nuclear
erlays of KRT7þ/Notch2þ imCTBs with nuclear N2ICD.
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expression pattern of Notch2 and its putative ligands in different
trophoblast subtypes [16] suggest a vital role of the receptor in
murine placentation.
Similar to mice, Notch signalling could also regulate human
trophoblast function and/or differentiation. Indeed, Notch re-
ceptors and ligands were detected in the diverse CTB populations of
ﬁrst and second trimester placenta and changes in gene expression
between normal and preeclamptic placental tissues were noticed
[15,17e19]. Chemical inhibition of g-secretase and siRNA-mediated
gene silencing of RBPJk increased proliferation of villous CTBs
(vCTBs) and cell column trophoblasts (CCTs) in ﬁrst trimester
villous explant cultures as well as EVT marker expression in pri-
mary CTBs suggesting that canonical Notch signalling could control
the differentiation program of anchoring villi [18,20]. The role of
individual Notch receptors, however, has not been elucidated in
human trophoblasts. To gainmore insights into speciﬁc functions of
Notch we herein analysed the expression pattern of Notch2 in
different trophoblast subtypes and studied its role in trophoblast
proliferation and EVT migration.
2. Materials and methods
2.1. Tissue collection
First trimester placental (n ¼ 50) and decidual (n ¼ 5) specimens were gained
from elective terminations. Tissues were collected with written informed consent
and utilization was approved by the Ethics Committee of the Medical University of
Vienna.
2.2. Cultivation of primary human ﬁrst trimester CTBs and SGHPL-5 cells
Primary human CTBs were isolated from ﬁrst trimester placentae according to a
modiﬁed protocol of Tarrade et al. [21], as previously published [18,20,22]. Puriﬁed
trophoblasts were seeded onto ﬁbronectin-coated (20 mg/ml; BD Biosciences,
Franklin Lakes, NJ) wells at a density of 5105 cells/24-well. To isolate CTB subtypes,Fig. 2. Expression of Notch2 and EVT markers in EGFRþ and HLA-Gþ CTBs isolated from ﬁ
(ITGA1) and integrin a5 (ITGA5) in the two different CTB populations using qRT-PCR. Me
quantiﬁcation (AU, arbitrary units) values of each target gene were arbitrarily set to 1 in EGF
were elevated in HLA-Gþ CTBs compared to EGFRþ CTBs, the latter expressing high levels of
types analysed by Western blotting. In agreement with the mRNA expression data HLA-Gþ CT
established as a marker of EVT [27,29]. GAPDH was used as loading control.magnetic bead sorting (MACS) was used to separate proliferative, EGFRþ CTBs from
differentiated, HLA-Gþ CTBs. EGFR-PE antibody (Santa Cruz Biotechnology, Dallas,
TX) or HLA-G-PE antibody (Exbio, Praha, Czech Republic) and anti-PE micro-beads
(Miltenyi Biotec, Bergisch Gladbach, Germany) were utilised. SGHPL-5 cells were
cultivated in DMEM/Ham's F12, supplemented with 10% FCS and 0.05 mg/ml
gentamicin as published [23].2.3. Immunoﬂuorescence analysis
First trimester placental/decidual tissues and ﬂoating placental explants were
ﬁxed in 7.5% formaldehyde and embedded in parafﬁn (Merck Millipore, Darmstadt,
Germany). Serial sections of these samples were deparafﬁnised and antigens
retrieved in PT Module Buffer 1 (100 citrate buffer, pH 6; Thermo Fisher Scientiﬁc)
by KOS MicrowaveStation (Milestone Srl, Sorisole, Italy). Sections were incubated
with primary antibodies against Cytokeratin-7 (OV-TL 12/13, DAKO, 1:100), Cyto-
keratin wide spectrum (GeneTex, GTX29377, 1:100), DLL1 (ab76655, Abcam, 1:100),
DLL4 (PAB10200, Abnova, 1:100), HLA-G (MEM-G/9, Exbio, 1:100), Jagged1 (H-114,
Santa Cruz Biotechnology, 1:100), Jagged2 (C23D2, Cell Signaling, 1:100), Notch2
(D76A6, Cell Signaling, 1:100), HAI-1 (H180, Santa Cruz, 1:100) or VE-Cadherin (BV9,
Abcam, 1:100) at 4 C overnight. Normal Rabbit IgG (Cell Signaling, 1:100) and
Rabbit mAb IgG (DA1E, Cell Signaling, 1:250) were used as negative controls (not
shown). Subsequently, sections were incubated with goat anti-mouse or anti-rabbit
IgG conjugated to Alexa Fluor 488 or Alexa Fluor 568 (2 mg/ml; Molecular Probes,
Life Technologies) for 1 h at room temperature. All sections were counterstained
with DAPI (1 mg/ml; Roche Diagnostics, Mannheim, Germany). Images were ac-
quired on a ﬂuorescence microscope (Olympus BX50, CC12 digital camera, Cell^ P
software, Olympus, Hamburg, Germany).2.4. Quantitative RT-PCR
RNA was isolated using peqGOLD TriFast™ (PEQLAB, Biotechnologie GmbH,
Erlangen, Germany). Amount and purity were measured with NanoDrop spectro-
photometer (ND-1000, PEQLAB). cDNA synthesis, qRT-PCR and data analysis were
performed as previously described [24], using 7500 Fast Real-Time PCR System
(Applied Biosystems). The FAM™ dye-labelled TaqMan® MGB probes (Applied Bio-
systems) utilised were EGFR (Hs00193306_m1), HLA-G (Hs00365950_g1), ITGA1
(Hs00235006_m1), ITGA5 (Hs01547673_m1) Notch2 (Hs01050702_m1) and HES1
(Hs00172878_m1). The housekeeping gene TATA-binding protein (TBP; 4333769F)
was used as endogenous control.rst trimester placental tissue. (A) Transcript levels of Notch2, EGFR, HLA-G, integrin a1
an values ± S.D. obtained from ﬁve different CTB isolations are shown. For relative
Rþ CTBs. *p < 0.05. Consistent with EVT differentiation HLA-G, ITGA1 and ITGA5 mRNAs
EGFR. (B) Protein levels of Notch2, EGFR, HLA-G and TCF-4 in the two puriﬁed CTB cell
Bs expressed increased levels of Notch2, HLA-G and TCF-4. The latter has been recently
Fig. 3. siRNA-mediated Notch2 knockdown or antibody-mediated inhibition of Notch2-
dependent signalling increase motility of primary CTBs and SGHPL-5 cells through
ﬁbronectin-coatedtranswells. (A)Migration in thepresenceofNotch2siRNA(siN2)ornon-
targeting control (ntc). Bars represent mean values ± S.D. obtained from each three CTB
isolations/SGHPL-5 cell experiments performed in duplicates. ntc was arbitrarily set to
100%. *p < 0.05. (B) Migration upon addition of Notch2 blocking antibody (N2AB) or IgG
control (IgG ctrl). Bars represent mean values ± S.D. obtained from three experiments
performed in duplicates. IgG control was arbitrarily set to 100%. *p < 0.05.
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Protein lysates were separated by SDS-PAGE, blotted onto methanol-activated
PVDF membranes (GE Healthcare, Buckinghamshire, U.K.) and incubated with pri-
mary antibodies against EGFR (D38B1, Cell Signaling, 1:1000), GAPDH (14C10, Cell
Signaling, 1:1000), HLA-G (MEM-G/9, Exbio, 1:500), Notch2 (D76A6, Cell Signaling,
1:1000) and TCF-4 (C9B9, Cell Signaling, 1:1000) at 4 C overnight. Finally, the blots
were incubated with HRP-linked anti-mouse (1:25,000; GE-Healthcare) or anti-
rabbit (1:5.000; Cell Signaling Technology, Danvers, MA) IgG secondary antibodies
for 1 h at room temperature and developed with ECL Prime Western blotting
detection reagent (GE Healthcare). The proteins were visualised with MultiImage III
FC Light Cabinet and Alpha View 3.1.1.0 software (Alpha Innotech, San Leandro, CA).
2.6. siRNA-mediated gene silencing and inhibition of Notch2
For siRNA-mediated silencing primary CTBs were transfected with non-
targeting control siRNAs (D-001810-01-05) or Notch2 siRNAs (L-012235-00; ON-
TARGETplus SMARTpools, Dharmacon-Thermo Fisher Scientiﬁc, Waltham, CA) us-
ing the 4D-Nucleofector (program EO-100) and Amaxa SG Cell Line 4D Nucleofector
X Kit L (Lonza, Basel, Switzerland). SGHPL-5 cells were transfected by using Lip-
ofectamine RNAiMAX transfection reagent (Life Technologies). For speciﬁc inhibi-
tion of Notch2 signalling, cultivated cells were treated with 0.4 mg/ml Notch2
blocking antibody or 0.4 mg/ml human IgG isotype control (Novus Biologicals, Lit-
tleton, CO). The blocking antibody binds and stabilises the negative regulatory re-
gion of the receptor, thereby inhibiting conformational changes, ADAM mediated-
cleavage and Notch2-ICD (N2ICD)-dependent activation of canonical signalling
[25] as also recently published [26].
2.7. Migration assay
24 h after siRNA transfection or treatment with Notch2 blocking antibody cells
were seeded onto ﬁbronectin-coated transwells (Merck Millipore, 12 mm pore size
for trophoblasts, 8 mm for SGHPL-5 cells). After additional 24 h inserts were ﬁxed
with 4% paraformaldehyde and nuclei of migrated cells were stained with DAPI and
visualised by ﬂuorescence microscopy. Five non-overlapping pictures per mem-
brane were taken at a 40-fold magniﬁcation and digitally analysed with ImageJ
software as published [20].
2.8. Proliferation assay
Proliferation in placental villous explant cultures and isolated CTBs was analysed
by EdU-Click 488 (baseclick GmbH, Tutzing, Germany). Primary cells and ﬂoating
explants, dissected from ﬁrst trimester placenta, were cultivated overnight in
DMEM/Ham's F12 in the presence of 10 mM EdU and 0.4 mg/ml Notch2 blocking
antibody or 0.4 mg/ml IgG isotype control and subsequently processed for immu-
noﬂuorescence analysis as mentioned [18,20].
2.9. Luciferase assay
Primary CTBs and SGHPL-5 cells were transfected with 1 mg/ml of a luciferase
reporter plasmid containing four RBPJk binding sites and 0.5 mg/ml pCMV-b-galac-
tosidase (CMV-bGal, normalisation control) as previously mentioned [20]. Trans-
fected cells were cultivated overnight with the Notch2 blocking antibody.
Subsequently, cells were lysed in cell culture lysis buffer (Promega, Madison, WI)
containing protease inhibitor cocktail (1:100; Invitrogen-Life Technologies). b-
galactosidase and luciferase activities were measured as previously published
[18,27].
2.10. Statistical analysis
Statistical analysis was performed with Student's t-test or Welch's test using
SPSS version 17 (IBM Corporation, Armonk, NY). A p-value <0.05 was consid-
ered statistically signiﬁcant. Gaussian distribution and equality of variances
were determined with KolmogoroveSmirnov test and Levene's test,
respectively.
3. Results
3.1. Notch2 predominantly localizes to differentiated HLA-Gþ CTBs
Immunoﬂuorescence of ﬁrst trimester placental tissues revealed
expression of Notch2 in the villous core, in vCTBs as well as in CCTs
(Fig. 1). Notch2 increased in distal areas of the cell column and was
also abundantly expressed in migratory HLA-Gþ interstitial CTBs
(iCTBs) of decidua basalis as well as in intramural cytotrophoblasts
(imCTBs) surrounding maternal blood vessels (Fig. 1). Several of the
imCTBs exhibited nuclear Notch2 staining. Closer inspection of
arterial vessels harbouring cytokertatin 7þ imCTBs revealed that
the adjacent maternal endothelial cell (EC) layer expressed theNotch ligands DLL1, DLL4, JAG1 and JAG2 (Supplementary Fig. 1).
DLL1 and JAG2 were also strongly expressed in iCTBs and imCTBs,
whereas these CTB subtypes weakly produced DLL4 and JAG1
(Supplementary Fig. 1).
3.2. Notch2 expression is associated with EVT differentiation
Notch2 was measured by qRT-PCR and Western blotting in
EGFRþ CTBs and HLA-Gþ EVTs isolated from ﬁrst trimester
placentae using MACS (Fig. 2). Both Notch2 mRNA (Fig. 2A) and
protein (Fig. 2B) were elevated in the HLA-Gþ cell pool conﬁrming
immunoﬂuorescence data.
3.3. Notch2 impairs trophoblast migration
To assess the role of Notch2 in trophoblast migration (Fig. 3)
SGHPL-5 cells and primary ﬁrst trimester CTBs were treated with
Notch2 siRNAs or speciﬁc blocking antibodies preventing Notch2
cleavage and therefore N2ICD-dependent transcription. Transfection
with Notch2 siRNA decreased Notch2 protein levels in cellular ex-
tracts of SGHPL-5 cells and primary CTBs (Supplementary Fig. 2).
Efﬁcacy of the Notch2 blocking antibody was conﬁrmed by down-
regulation of canonical Notch reporter activity in the two cell types
(Supplementary Fig. 3). Both siRNA-mediated gene silencing
(Fig. 3A) and inhibition of Notch2 cleavage (Fig. 3B) increased
migration of primary CTBs and SGHPL-5 cells through ﬁbronectin-
coated transwells.
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Advantageous over siRNA treatment, treatmentwith the blocking
antibody allows for immediate inhibition of Notch2-dependent sig-
nalling. Hence, proliferation in ﬂoating villous explant cultures was
assessed in the presence of the inhibitory Notch2 antibody by using
immunoﬂourescent EdU labelling (Fig. 4A). However, evaluation of
the percentage of EdUþ vCTBs and CCTs cells did not reveal any dif-
ferences between cultures treated with the blocking antibody or IgG
control (Fig. 4B) although efﬁcient downregulation of the canonical
Notch target gene HES1 was observed (Supplementary Fig. 4).
Accordingly, inhibition of Notch2 cleavage did neither affect EdU
incorporation into isolated primary CTBs (Fig. 4C), nor outgrowth in
villous explant cultures seeded on collagen I (data not shown).
4. Discussion
Descriptive studies suggest complex roles for Notch2 in the
developing mouse placenta. Notch2 expression varies dynamically
throughout mouse gestation and complementary expression of
the receptor and its potential interacting ligands have been
detected in neighbouring trophoblasts of the ectoplacental cone
and labyrinth [16]. Moreover, Notch2 is the predominant receptorFig. 4. Antibody-mediated inhibition of Notch2-dependent signalling in ﬁrst trimester ﬂo
incorporation and counting of the EdU/DAPI ratio. (A) Representative pictures (scale bars re
treated with Notch2 blocking antibody (N2AB) or IgG control (IgG ctrl). Upper and lower pa
EdUþ vCTBs and CCTs are indicated by arrows. CCT, cell column trophoblast; VC, villous core
explants isolated from three different placentae were evaluated in the presence of N2AB o
2400e2600 nuclei of CCTs per condition. (C) Percentage of EdUþ primary CTBs after treatme
performed in duplicates. n.s., not signiﬁcant.in differentiated, invasive trophoblast cell types such as interstitial
glycogen trophoblasts and trophoblast giant cells lining spiral
arteries and arterial canals [14e16]. Similar to mice, the present
study shows that Notch2 expression is mainly associated with
differentiated HLA-Gþ CTB subtypes. Both immunoﬂuorescence in
ﬁrst trimester placental tissues and analyses of primary CTB pools
isolated by MACS suggested that Notch2 expression increased
during EVT differentiation, the latter being characterised by the
induction of marker genes such as HLA-G, ITGA1 and ITGA5. Be-
sides elevated expression in HLA-Gþ dCCTs, Notch2 was also
abundant in iCTBs and imCTBs of ﬁrst trimester decidua basalis.
These data are in agreement with previous analyses of second
trimester basal plate biopsies showing expression of Notch2 in the
different invasive trophoblast cell types [15]. Furthermore,
immunoﬂuorescence with the Notch2 antibody, recognizing a
membrane-bound, intermediate cleavage product as well as nu-
clear Notch2, indicated that N2ICD was partly present in imCTB
nuclei. The maternal EC layer adjacent to imCTBs expressed JAG1,
JAG2, DLL1 and DLL4. Therefore, we speculate that putative
binding of maternally-expressed ligands to the Notch2 receptor
present on imCTBs could activate canonical, N2ICD-dependent
signalling and thereby eventually contribute to remodelling of
maternal arterial vessel. In agreement with this assumption,ating villous explant cultures and primary CTBs. Proliferation was analysed by EdU
present 50 mm) showing immunoﬂuorescent EdU staining in ﬂoating explant cultures
nel show EdU labelling in HAI1þ vCTBs and KRT7þ CCTs. Nuclei are stained with DAPI.
; vCTB, villous cytotrophoblasts. (B) Percentage of EdUþ villous CTBs and CCTs. Each 14
r IgG ctrl. Bar graphs represent mean values ± S.D. of 1200e1400 nuclei of vCTBs and
nt with N2AB or IgG ctrl. Bar graphs represent mean values ± S.D. of three experiments
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invasion and placental perfusion. Conditional deletion of Notch2 in
progenitors of the invasive trophoblast lineage decreased endo-
vascular invasion of spiral arteries and the diameter of maternal
canals which deliver blood to the developing placenta [15].
Besides its role in endovascular invasion and remodelling,
Notch2 and its interacting ligands could have diverse roles at the
placentaledecidual interface, likely depending on their respective
expression by adjacent interacting cell types. For example, decidual
stromal cells, which were shown to control endogenous prolactin
and IGFBP-1 expression via Notch2 activation, express DLL1 and
DLL4 in a differentiation-dependent manner [26]. The latter ligand
impaired in vitro migration of puriﬁed CTBs [18]. Moreover, CD45þ
leukocytes of the decidua produce DLL1, DLL4 and JAG1 [26]. Hence,
tissue invasion of iCTBs expressing Notch2 could be controlled by
ligands present on interacting decidual stromal cells, macrophages
or uterine NK cells. On the other hand, we speculate that ligands
expressed by iCTBs could possibly activate Notch2 in stromal cells
and thereby control decidual marker gene expression. In this
context it is also noteworthy that both DLL1 and DLL4 were shown
to activate Notch signalling in decidual NK cells promoting inter-
feron-g secretion [28].
Moreover, Notch2 could also play a role in the distal cell column
where HLA-Gþ trophoblasts exhibit cellecell contact before they
undergo further differentiation steps along the invasive pathway.
Indeed, inhibition of Notch2 cleavage with a speciﬁc blocking
antibody as well as siRNA-mediated Notch2 silencing increased
migration of SGHPL-5 cells and primary CTBs. These data are in
agreement with our recent observation showing that chemical in-
hibition of g-secretase, blocking canonical NICD-dependent sig-
nalling, also increased EVT motility [18]. Therefore, we speculate
that activation of Notch2 by neighbouring HLA-Gþ CCTs could
positively affect cell column integrity and thereby impair tropho-
blast detachment and migration. Since HLA-Gþ CCTs express DLL1,
DLL4, JAG1 and JAG2 [18], different Notch2-ligand interactions
could be involved.
Concurrent with the weak expression of Notch2 in EGFRþ CTBs,
blocking of N2ICD-dependent signalling did not affect proliferation
of CCTs in villous explants cultures and isolated primary cells. In
contrast, inhibition of g-secretase and silencing of RBPJk were
shown to increase cell column proliferation and trophoblast
outgrowth in these organ cultures [18,20]. The latter treatments
also elevated HLA-G, ITGA1, ITGA5 and TCF-4 expression in differ-
entiating CTBs [18,20], whereas these EVT markers were not
affected upon antibody-mediated inhibition of Notch2 cleavage
(data not shown). Therefore, we assume that the main role of
Notch2 is to regulate features of HLA-Gþ CCTs and different EVT
subtypes, whereas other receptors of the proximal cell column,
such as Notch1, 3 or 4 [15,18], could control balanced rates of
trophoblast proliferation and EVT differentiation. In analogy to that,
murine Notch2 was shown to promote endovascular trophoblast
invasion but not trophoblast lineage development [14,15].
Depending on the interacting cell type and the expression pattern
of ligands Notch2 could regulate column integrity, trophoblast
migration, decidual cell function and vessel remodelling.
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